Discover
SLXN
Silexion Therapeutics Corp
0.44
2 x 0.24
2 x 0.34
bid
ask
+
0.06
14.61%
2 @ 07:56 PM
0.41 -0.03 (6.91%)
| Ytd | -97.73% | |
| 1y | -98.79% |
0.38
day range
0.45
0.34
52 week range
40.00
| Open | 0.39 | Prev Close | 0.38 | Low | 0.38 | High | 0.45 | Mkt Cap | 2.42M |
| Vol | 27.81M | Avg Vol | 3.00M | EPS | -19.89 | P/E | N/A | Forward P/E | -3.95 |
| Beta | -0.11 | Short Ratio | 0.23 | Inst. Own | 8.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.25 | 200-d Avg | 10.45 | 1yr Est | 9.00 |
| Income Statement | |||
| Operating Expenses | 3.68M | ||
| Research and Development Expense | 2.21M | ||
| Selling, General and Administrative Expense | 1.47M | ||
| Operating Income | -3.68M | ||
| Interest Expense | -129.00K | ||
| Net Income | -3.55M | ||
| Net Income Common Stock | -3.55M | ||
| Net Income Common Stock (USD) | -3.55M | ||
| Consolidated Income | -3.55M | ||
| Earnings per Basic Share | -5.17 | ||
| Earnings per Basic Share (USD) | -5.17 | ||
| Earnings per Diluted Share | -5.17 | ||
| Earning Before Interest & Taxes (EBIT) | -3.68M | ||
| Earning Before Interest & Taxes (USD) | -3.68M | ||
| Weighted Average Shares | 687.35K | ||
| Weighted Average Shares Diluted | 687.35K | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.26M | ||
| Cash and Equivalents (USD) | 2.26M | ||
| Investments | 62.00K | ||
| Investments Non-Current | 62.00K | ||
| Current Assets | 3.74M | ||
| Property, Plant & Equipment Net | 368.00K | ||
| Total Assets | 4.25M | ||
| Debt Current | 1.18M | ||
| Total Debt | 1.41M | ||
| Current Liabilities | 3.98M | ||
| Debt Non-Current | 226.00K | ||
| Total Liabilities | 4.20M | ||
| Accumulated Retained Earnings (Deficit) | -61.45M | ||
| Shareholders Equity | 44.00K | ||
| Shareholders Equity (USD) | 44.00K | ||
| Assets Non-Current | 505.00K | ||
| Total Debt (USD) | 1.41M | ||
| Liabilities Non-Current | 226.00K | ||
| Trade and Non-Trade Payables | 2.16M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.00K | ||
| Net Cash Flow from Financing | 2.74M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -186.00K | ||
| Issuance (Purchase) of Equity Shares | 2.98M | ||
| Net Cash Flow from Investing | -1000 | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -1000 | ||
| Net Cash Flow from Operations | -2.92M | ||
| Effect of Exchange Rate Changes on Cash | 8.00K | ||
| Share Based Compensation | 197.00K | ||